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Abstract
Mendelian disorders are often caused by mutations in genes that are not lethal but induce functional distortions leading to
diseases. Here we study the extent of gene duplicates that might compensate genes causing monogenic diseases. We
provide evidence for pervasive functional redundancy of human monogenic disease genes (MDs) by duplicates by
manifesting 1) genes involved in human genetic disorders are enriched in duplicates and 2) duplicated disease genes tend
to have higher functional similarities with their closest paralogs in contrast to duplicated non-disease genes of similar age.
We propose that functional compensation by duplication of genes masks the phenotypic effects of deleterious mutations
and reduces the probability of purging the defective genes from the human population; this functional compensation could
be further enhanced by higher purification selection between disease genes and their duplicates as well as their
orthologous counterpart compared to non-disease genes. However, due to the intrinsic expression stochasticity among
individuals, the deleterious mutations could still be present as genetic diseases in some subpopulations where the duplicate
copies are expressed at low abundances. Consequently the defective genes are linked to genetic disorders while they
continue propagating within the population. Our results provide insight into the molecular basis underlying the spreading
of duplicated disease genes.
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Introduction
Elucidating the molecular basis of human genetic disorders is
one of the most important tasks in medical biology. The
availability of the human genome sequence [1,2] has facilitated
the identification of individual disease genes, e.g. in family
pedigree analyses [3] as well as genome-wide association studies
(GWAS) [4,5]. Exploring the characteristics of known disease
genes and differences from non-disease genes using bioinformatics
methods in recent studies has provided, for example, knowledge of
their function [6], evolutionary origin [7,8], selective constraints
[9–11] and network properties in the protein-protein interaction
(PPI) network [12–14], and insights into the genetics underpinning
human inherited disorders, facilitating in silico identification of
novel disease genes [9,11].
However, recent studies have revealed some controversial
findings related to duplicated genes and no clear explanation has
been given so far. For example, the accepted hypothesis was that
disease genes tend to be singletons with fewer paralogs [15] since
duplication can lead to functional redundancy [16–18] and
thereby mask the effect of deleterious mutations [15,19]; however,
disease genes were found surprisingly enriched in duplicates [8].
Moreover, the molecular mechanism by which the duplication
statuses of disease genes contribute to their increased presence in
the human genome is still unclear. Recently, it has been proposed
that the presence of duplicates permits the accumulation of
disease-causing mutations, the emergence of disease genes thus
would be more likely to associate with duplicates [8]. Here we
argue that this line of reasoning does not necessarily predict the
enrichment of disease genes in duplicates even when the
compensational capacity between duplicates is considered. For
example, in duplicates (i.e. more recent ones) whose functional
redundancy is resilient enough to mask some disease-causing
mutations in one of the copies, the proportion of disease genes
would be lower compared with that of overall singletons; however,
for duplicates (i.e. older ones) whose compensation capacity is
partial or no longer effective, they would be purged from the
human genome at the same rate as singletons; combined together,
the overall proportion of disease genes in duplicates would still be
lower. Summarizing recent literature, we realized that the
duplication-functional redundancy theory alone is perhaps insuf-
ficient in explaining the observed enrichment of disease genes in
duplicates, and the contribution of additional factors should be
explored and taken into consideration.
In this work, we sought to provide a clear illustration on the
evolutionary forces governing the propagation of disease genes in
the human population by surveying exhaustively the characteris-
tics of disease genes and comparing those with non-disease genes.
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We focused on monogenic disease genes (MDs) that have a clear
association with and contribution to human genetic disorders, and
tried to address the following questions. First, can the enrichment
of disease genes in duplicates first revealed by Dickerson et al [8]
be reproduced in an updated dataset and what are the
contributions of multiple paralogs in multi-gene families? Second,
if disease genes indeed tend to have functional backups, is this
supported by evidence showing a higher functional similarity
between paralogs of disease genes than paralogs of non-disease
genes? A key factor being, if the functional divergence of disease
genes is greater than that of non-disease genes, a lower or
comparable proportion of disease genes in duplicates would be
expected, mimicking a behavior that of singletons. Due to the
divergence of the functional redundancy of duplicated genes [20]
stratification of the genes according to their duplication age was
necessary, otherwise resulting in false conclusions as shown in [21].
Third, what are the evolutionary factors acting on human disease
genes within and/or across species that could contribute further to
the functional compensation of duplicated disease genes? And
finally, what are the molecular mechanisms underlying the
spreading of disease genes as duplicates or singletons in the
human population? In other words, how could the functional
redundancy between duplicates actually increase their likelihood
of being disease genes?
Results
Disease genes are enriched in duplicated genes
Initially, we investigated the duplications of human disease
genes. Here, we considered three widely used approaches to detect
duplicated genes in the human genome, including those based on
simple homology (FASTA), gene family evolution (TreeFam) and
orthology (eggNOG v3) (see Methods) which resulted in similar
conclusions for all methods (Figures S1 and S2). As shown in
Figure 1, we found that 55% monogenic disease genes (MDs) were
duplicates, a significantly higher fraction than in non-disease genes
(NDs; p=261028; Fisher’s Exact Test); similarly, we found 23%
of the duplicates are also MDs, compared to 18% in singletons
(Figure 1B; see also Dataset S1). Since duplicates are often found
Author Summary
Duplicated genes, as opposed to singletons, are genes that
have additional copies in a genome due to evolutionary
mechanisms such as whole genome duplication, homol-
ogous recombination or retrotransposition events. Dupli-
cates can have similar functions and thus mask the
phenotypic consequences when one copy is mutated.
Conversely, the corresponding phenotypes would mani-
fest themselves when mutations occur in singletons, since
functional compensation is rare among non-duplicated
genes. It would thus be expected that the primary source
of monogenic diseases, diseases caused by mutations
within a single gene, is singletons. However, the opposite
was found to be true. Additionally, we found the
functional similarity of duplicated disease genes to be
greater than that of duplicated non-disease genes of an
equivalent duplication age. So how could the stronger
functional compensation among duplicates increase their
likelihood to associate with diseases? We propose that due
to functional compensation in duplicates, disease-causing
mutations are less likely to be removed from a human
population in large scale since the phenotypes are
masked; however, the functional compensation could be
lost in a subpopulation, perhaps due to intrinsic variation
in gene expression, and therefore lead to diseases. As a
result, the duplicated disease genes are linked to genetic
diseases, yet they continue to spread within the human
population.
Figure 1. Duplicated genes are enriched in monogenic disease genes. A) percentages of duplicates in monogenic disease genes (MD) and
non-disease genes (ND). B) percentages of monogenic disease genes as function of number of duplicates in human; 0 indicates that genes are
singletons. Here duplicates were defined using TreeFam. P-value shown in panel A was calculated using Fisher’s Exact Test; level of significance:
*** ,0.001, ** ,0.01, * ,0.05. Numbers shown within the bars are gene counts (subset/total).
doi:10.1371/journal.pcbi.1003073.g001
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to be functionally compensating [16], our results suggest disease
genes are enriched in functional backups. Strikingly, we found that
the number of paralogs in the same gene family did not have a
significant impact on gene disease status (Figures 1B, S1B and
S2B), suggesting non-additive functional compensation from
multiple gene family members.
Functional redundancy in duplicated disease genes
We next sought to find additional evidence for functional
redundancy in duplicated disease genes by comparing with
duplicated non-disease genes. Since the functional redundancy
between duplicates decreases over time [20], it is essential to
compare duplicates of a similar age. We therefore first divided
duplication pairs (gene-closest paralog) into distinct groups
according to their duplication age, and then divided them into
disease gene containing pairs, if at least one gene in a pair is
disease-related (MD-pairs), and non-disease gene containing pairs
otherwise (ND-pairs) (see Methods).
Evidence from unbiased datasets. We first of all analyzed
the differential expression patterns and sequence divergences
between duplicated genes, which are widely believed to be
important indicators of functional similarities [22].
Using gene expression profiles in 36 human normal tissues
obtained from [23], we found that the co-expressions between
MDs and their closest paralogs are in general higher than that of
non-disease genes of similar duplication age (Figure 2A; duplica-
tion age delineated by the total branch length from the node
representing where the duplication event happened on the species
tree to the leaf node of human; see Methods); this is also true when
ages are omitted (Figure 2B). Additionally, we found the co-
expressions tend to decrease with increasing duplication age,
consistent with previous studies [20]. The same results can be
obtained using the expression data from [24] (Figure S3).
Similarly, we found that the protein sequence identities of MD-
pairs are higher than that of ND-pairs of similar age. Similar to the
co-expression results, the sequence identity in general correlates
negatively with the divergent time, as shown in Figure 2C. Thus in
both datasets we obtained consistent results indicating higher
functional similarities between monogenic disease genes and their
closest paralogs than for ND paralog pairs. Since all genes in the
two datasets are either present (e.g. protein sequences) or have an
equal possibility to be present (e.g. gene expression data from
microarrays), we considered the two datasets unbiased.
Additional evidence from biased/incomplete
datasets. We then compared the characteristics between MD-
with ND-pairs using two additional datasets, namely Gene
Ontology (GO) and human physical protein-protein interactions
(PPIs). GO annotations are known to be biased towards highly
expressed and more conserved genes [25]; the same would also
apply to the PPI data. Additionally, current GO annotation and
human PPI network only cover limited numbers of genes;
consequently, only ,37% duplication pairs were annotated by
GO, and ,36% by PPIs. We thus considered the two datasets
biased.
We obtained GO annotations for human gene products from
Ensembl Biomart and used the Bioconductor package GOSem-
Sim [26] to measure semantic similarities between GO terms
associated with duplicate genes (see Methods). In light of recent
discussions on possible biases in GO and wrong interpretations of
the results due to the biases [27,28], we tested whether disease and
non-disease genes were equally represented in the GO annota-
tions. We found MD genes were significantly better annotated by
GO and associated with more GO terms (p=2.36610232,
Wilcoxon Rank Sum Test; Figure S4); the GOSemSim value
measured on a pair of duplicated genes is inversely correlated with
the maximum number of GO terms of individual genes associated
with in a pair (Pearson’s correlation: p=1.12610235, R=20.27).
We therefore adopted a normalized version of GOSemSim as an
approximation for functional redundancy. As shown in Figure 3,
we found disease genes tend to have similar functions with their
closest paralogs compared with that of non-disease genes of similar
age (Figure 3A); the same results could be obtained when age was
omitted (Figure 3B).
Similarly, by calculating the percentage of shared PPI partners
between duplicates, we found disease genes also tend to have
higher functional similarity with their duplicates than non-disease
genes (Figure S5). Thus all the datasets generated consistent
results, thereby providing extensive evidence for the pervasive
functional redundancy by duplicates for human monogenic disease
genes.
Higher purifying selections on duplicated disease genes
Previous studies suggested that disease genes were under
purifying selections compared with non-disease genes, by measur-
ing the numbers of nonsynonymous substitutions per nonsynon-
ymous site (dN) between human-mouse orthologs [11]. We
confirmed these observations in our dataset using one-to-one
orthologs between human and mouse, as well as those between
human and macaque; the results are shown in Figure 4A and 4B,
respectively. Furthermore, we found the selective constraints on
disease duplicates are higher than on disease singletons (genes that
do not have homologs in the human genome), as shown in
Figure 4C and 4D.
The higher purifying selection on duplicated disease genes can
also be observed within the human genome; as shown in Figure 4E,
we found that MD- pairs always have lower dN values than ND-
pairs of similar age.
Discussion
In summary, we have made two interesting observations
regarding disease genes in duplicates. First, we have shown that
human monogenic disease genes tend to frequently have
functionally redundant paralogs, by comparing their characteris-
tics to that of non-disease genes, stratifying both categories
according to duplication age. Second, duplicates tend to harbor
more disease genes than singletons, confirming the observation by
an earlier study [8], but contradicting theoretical expectations.
What are possible explanations for these observations? A
possible scenario is that a disease gene and its duplicate are
simultaneously required for certain functions; for example, they
might be involved in the same protein complex. In this case, the
two genes would be highly co-expressed and evolve similarly.
However this is unlikely because the so-called ‘‘balance hypoth-
esis’’ – both underexpression and overexpression of protein
complex subunits would lower fitness of the host organism –
[29] predicts that 1) duplicates are rarely involved in protein
complexes and 2) the two duplicates from a common ancestor are
rarely retained by the same complex unless all other members of
the complex are also duplicated and the extra copies are also
retained; otherwise the protein complex is imbalanced and
evolutionarily deleterious [29]. We found that the first held true
in MDs as well as NDs in human using a protein complex dataset
from [30], and comparing them with non-disease genes. Disease
genes and their closest paralogs are significantly less likely to be
involved in the same complexes (p=0.0002, Odds Ratio = 0.57;
Fisher’s Exact Test). These results are consistent with a previous
study in which only one gene out of a pair of duplicates was found
Frequent Redundancy for Duplicated Disease Genes
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to be associated with diseases [8]. A previous study suggested that
duplicates associated with whole genome duplications (WGDs) are
dosage balanced [31] and thus might not abide by the balance
hypothesis. However, we found that pairs of WGD duplicates do
not have a high likelihood to be in the same complexes compared
with pairs of duplicates associated with small scale duplicates
Figure 2. Evidence for functional redundancy in duplicated disease genes. Comparing with duplicated non-disease genes (ND) of similar
duplication age (represented by branch length, see Methods), monogenic disease genes (MD) tend have A) higher co-expression co-efficient (p-
value = 1.6961023, Hypergeometric Distribution test), C) higher sequence similarity (p-value = 1.6661023, Hypergeometric Distribution test). Results
in A) can be repeated using another set of gene expression data (Figure S3). P-values shown in the boxplots (B and D) were calculated using two-
sample Wilcoxon Rank Sum Test; see Materials and Methods for more details regarding the statistical tests. Numbers shown next the boxplots are the
numbers of valid samples (after removing samples with missing values).
doi:10.1371/journal.pcbi.1003073.g002
Figure 3. Evidence for pervasive functional redundancy in duplicated disease genes based on Gene Ontology annotations.
Compared with duplicated non-disease genes (ND) of similar duplication age (represented by branch length, see Methods), monogenic disease genes
(MD) tend to have A) higher functional similarity according to Gene Ontology annotations with their most recent duplications (MRDs; p-
value = 7.7761025, Hypergeometric Distribution test); B) the same are also true when duplication ages are omitted (Wilcoxon Rank Sum Test).
doi:10.1371/journal.pcbi.1003073.g003
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(SSDs) (p=0.22, Fisher’s Exact Test); similar results could be
obtained (p=0.63; Fisher’s Exact Test) using protein complex data
from a genome-wide experimental survey on soluble proteins in
human [32]. Thus, WGD is not a confounding factor for our
observation.
So how could functional redundancy actually promote the
enrichment of disease genes in duplicates? Here we propose a new
model. We argue that functional compensation by duplication of genes
would help mask the phenotypic effects of deleterious mutations, as
previously suggested, and reduce the probability of purging the defect
genes from the human population. The functional compensation could
be further enhanced by the higher purifying selection on duplicated
disease genes within and between species. However, due to the intrinsic
expression stochasticity among individuals [33,34], the deleterious
mutations could present as genetic diseases in subpopulations where
the duplicate copies express in low abundances. In other words, the
corresponding genes would manifest as disease genes, while the mutant
allele would remain in the population instead of being removed. This
model is illustrated in more details in Figure 5. Consequently,
duplicates would be enriched in disease genes; the enrichment is weak,
albeit significant, due to the complexity of gene regulation in the
human genome.
Materials and Methods
Human genes and sequences
We obtained 21,731protein coding genes and the corre-
sponding protein and coding sequences (CDS) from Ensembl
[35] version 59. In cases one gene coding for multiple proteins,
the longest protein and the corresponding CDS is chosen as
representative.
All other gene annotations such as HGNC symbols, NCBI gene
IDs and accession numbers were mapped to Ensembl gene
identifiers to facilitate data integration. We downloaded the
mapping data using Ensembl BioMart.
Disease genes
We collected human disease genes from OMIM [36] and two
recent literatures [37,38]. In each of the sources disease genes were
divided into two categories, MDs – those associated with
monogenic diseases, and PDs – those associated with polygenic
diseases. We assigned genes associated with both types of diseases
into the MD group; please note that changing this definition, for
example by assigning this type of genes into the PD group did not
change our main conclusions (see Dataset S1).
Figure 4. Higher purifying selections on duplicated disease genes. Compared with non-disease genes (NDs), disease genes tend to have
lower dN values with their mouse- (A) and Macaca- (B) one-to-one orthologs. Furthermore, compared with disease singletons (singlet genes or
singletons refer to those that do not share significant protein sequence similarities with other human genes), duplicated disease genes tend to have
lower dN values with their mouse- (C) and Macaca- (D) orthologs. The higher selective constraints on duplicated disease genes can be also seen
within the human genome; for example, compared with duplicated non-disease genes (ND) of similar duplication age, disease genes tend to have
lower dN values with their closest paralogs within human (E; p-value= 461027, Hypergeometric Distribution test). However the same isn’t true when
age is omitted (F), highlighting the importance of dividing gene pairs according to their duplication age. P-values shown in the boxplots (A,D and F)
were calculated using two-sample Wilcoxon Rank Sum Test. A similar plot showing no outliers is also available in Figure S6.
doi:10.1371/journal.pcbi.1003073.g004
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All other genes that are not included in any of the three sources
are considered non-disease genes (NDs).
Duplicated genes
We used three approaches to find duplicated genes in the
human genome, including methods based simple homology search
(FASTA), gene family evolution (TreeFam [39]) and orthology
(eggNOG3 [40] using euNOG).
Using the homology-based method, if two human genes had a
bitscore higher than 80 in a FASTA [41] search at protein level,
and the aligned region covers at least 50% of the shorter protein,
they are considered as duplicates; please consult ref [21] for more
information about the chosen cutoffs. Changing the cutoffs, for
example by increasing the required proportion of the aligned
regions for homology detection did not affect our results; see
Figure S1 for more details.
In the latter two methods, if a gene family or an orthologous
group contains two or more human genes, these genes are
duplicates. The numbers of duplicated genes identified by the
three methods are 14,014, 14,084 and 11,853, respectively.
Dating duplication events on species tree
We downloaded all gene families as well as their corresponding
phylogenetic trees from TreeFam [39] ver8.0. We excluded gene
families that do not contain human genes, or contain genes from less
than four different species, resulting in a set of 9,643 gene families.
For each pair of duplicates in a gene family, we dated the (putative)
duplication event by comparing the topology of the corresponding
gene tree with that of a species tree. To compare with the TreeFam
gene trees, we used a species tree downloaded from Ensembl (http://
www.ensembl.org/info/docs/compara; see also Figure S8).
As shown in Figure S7, to date a duplication event of a pair of
duplicated genes (A2 and A3 in this case; see Figure S7A), we first
located their last common ancestor (LCA) on the gene tree, and
collected all the genes that are descendent to this LCA (Figure
S7A; in this case A_rat, A_mouse, A2_human and A3_human)
and their corresponding species (in this case human, mouse and
rat); then we mapped these species on to the species tree (Figure
S7B) and located the corresponding LCA; the age (divergent time)
of the duplication event was then defined as the total branch
length from this LCA to human on the species tree.
The trees shown in Figures S7 and S8 were visualized and
prepared using online tools, iTol [42] and EvolView [43].
Identifying duplicates associated with whole genome
duplications (WGDs)
Two rounds of whole genome duplication (WGDs) occurred
during early chordate evolution [44,45]. Duplicated genes for which
their duplication events can be dated back to that time are thus
likely to associated with WGDs. Using similar criteria to [31], we
were able to identify in total 6,560 genes with their most recent
duplication (MRD) ages dated after the split of human and Ciona
intestinalis (Ascidian), and before the split of human and fishes
including Takifugu rubripes (see also Figure S8); we found this number
of WGD associated duplicates remarkably similar to that of [31]
although different methods and numbers of species were used.
Gene expression profiles in normal tissues
We obtained the expression profiles of human genes in normal
tissues from two sources [23,24]; we were able to map 12,436 and
17,553 probe-sets to Ensembl 59 gene IDs for the two expression
datasets, respectively. Both datasets generated similar results.
Therefore we showed the results based on [23] in the main text;
results based on [24] are shown in Figure S3.
Gene ontology (GO) analyses
We downloaded GO annotations of human gene products from
Ensembl BioMart and GO term hierarchy file ‘gene_ontology_ext.
Figure 5. A model for the effect of functional compensation on the propagation of duplicated disease genes in the human
population. This model is based on two previous experimental studies. The first showed that genes with identical promoters could have very
different expression abundances in individual E. coli cells [33]. The second showed different C. elegans individuals carrying the defect gene could
demonstrate varying phenotypes ranging from wild type to stalled development on embryogenesis, depending on the expression abundance of a
duplicate gene [34]. We therefore propose that in cases where a duplicate (A1_human) exists (panel A), the functional impairment caused by
mutations on a disease gene (A2_human) could be compensated; however due to intrinsic expression stochasticity of the duplicate copy, some
individuals would appear to be normal while some others show reduced fitness (panel B). Consequently this gene A2 is linked to genetic disorders
while the deleterious mutations it carries continue to spread instead of being removed in the human population. On the other hand, if a disease gene
(B_human; panel C) is a singlet without any paralogs, its mutations then would be more likely to be purged from the population (panel D) since
compensation by non-duplicates via genetic interactions is relatively rare [16,17].
doi:10.1371/journal.pcbi.1003073.g005
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obo’ (format version 1.2; Feb 2012) from the Gene Ontology
database [46]. Genes (gene products) without GO annotations
were excluded from further analyses.
To compare functional redundancy based on semantic similar-
ity of GO terms between any given two genes, we used the
Bioconductor package GOSemSim [26]and restricted our analyses
on leaf-GO terms in ‘‘molecular function’’. Due to known biases
towards a better annotation for disease genes (see Results), we
adopted a normalized version of GOSemSim as the following
formula:
normalized GOSemSim~
GOSemSim  x{minz1ð Þ= max{minð Þ
where ‘x’ is the maximal number of GO terms associated with
individual genes in a duplication pair, ‘min’ is the minimal number
of GO terms associated with genes, ‘max’ is the maximal number
of GO terms associated with genes; ‘+1’ is used to avoid zeros.
Protein-protein interaction data
We collected the protein-protein interaction data from several
public databases, including STRING [47] (version 9,
score.=0.7), HPRD [48] (June 29, 2010), DIP [49] (Feb 28,
2012), MINT [50](Feb 6, 2012), IntAct [51] (Feb 7, 2012), and
BioGRID [52] (version 3.1.82), and considered only physical
bindings. In addition, we also included one experimental dataset
[53] and one curated dataset from the literature [54]. In total, we
obtained 80,202 interactions among 12,839 gene products.
dN values
For each pair of duplicates in the human genome, we used a
KaKs_Calculator [55] tool to calculate the dN (the numbers of
nonsynonymous substitutions per nonsynonymous site).
We also downloaded dN values between human genes and their
homologs in mouse and macaque from Ensembl [35] BioMart; we
retained entries with ‘‘Homology Type’’ of ‘‘apparent_ortholog_
one2one’’ or ‘‘ortholog_one2one’’.
Statistical tests
In this study we applied three statistical tests to different types of
datasets. 1) Fisher’s Exact Test. We used it to test whether monogenic
disease genes (MDs) are more likely to be duplicates compared with
non-disease genes (NDs). Since genes can be divided into four groups
according to two kinds of classifications (association with diseases and
being duplicates), it is suitable to use Fisher’s test. 2) Wilcoxon Rank
Sum Test. We used this test to compare two sets of numerical values
(for example two sets of dN values for MD and ND genes respectively)
and access whether one tends to have higher values than the other; in
this study it was often associated with boxplots. 3) Hypergeometric
Distribution Test. To test whether duplicated MD genes tend to have
higher functional redundancy with their most recent duplicates than
that of ND genes of similar age, each of the two groups would be
further divided into more than 10 age groups. We found in all cases,
the majority of the MD groups had higher (or lower) mean values than
the ND groups of the same age (for example Figure 2A). To check
whether such observations were significantly different from random
expectation, we applied the Hypergeometric Distribution Test using
the following function in R: phyper(q, m, n, k), where m refers the
number of cases where the mean values of the MD groups are higher
(or lower) in the pool, n refers the number of cases where the mean
values of the MD groups are lower (or higher) in the pool, k refers the
number of cases randomly chosen from the pool of m + n, and q refers
to the number of cases out of k where the mean values of the MD
groups are higher (or lower). In this study we set m=n=k= the
number of valid age groups. All tests were performed using R (http://
www.r-project.org/).
Availability of the materials and methods
All raw data and R scripts used in this study are available in
Dataset S1 as an archive file; also included in this archive is a
detailed instruction for the readers to reproduce our main results,
including all the figures, supplementary figures, and statistical tests
except Figure 5, which was plotted manually.
Supporting Information
Figure S1 Similar to Figure 1, only the duplicated genes were
detected using FASTA. Here we also tested the impact of different
cutoffs of aligned regions required for homology detection on our
results; four cutoffs were tested: 50% (A,B), 60% (C,D), 70% (E,F)
and 80% (G,H). A,C,E,G: percentages of duplicates in monogenic
genes and non-disease genes. B,D,F,H: percentages of monogenic
disease genes as function of number of duplicates in human; 0
indicates that genes are singletons (have no homologs in human).
(EPS)
Figure S2 The same as Figure 1, only the duplicated genes were
detected using eggNOG3. A) percentages of duplicates in
monogenic genes and non-disease genes. B) percentages of
monogenic disease genes as function of number of duplicates in
human; 0 indicates that genes are singletons.
(EPS)
Figure S3 A) Comparing with non-disease genes (NDs) of similar
duplication age, monogenic disease genes (MDs) tend to have higher
coexpression with their closest paralogs. B) the same is true when
age is omitted. The expression data were obtained from [24].
(EPS)
Figure S4 The number of unique GO terms (Molecular Function)
as a function of branch length in MD- and ND- pairs. A) number of
GO terms associated with a pair of genes in each group as a function of
duplication age. B) the same as A) but the age was omitted.
(EPS)
Figure S5 Higher functional similarities in MD pairs comparing
with ND-pair using protein-protein interaction data. A) shared
protein interaction partners of MD pairs were compared with ND-
pairs of similar age. B) the same as A) but the age was omitted.
(EPS)
Figure S6 The same as Figure 4, only the outliers were removed
from the plots. Compared with non-disease genes (NDs), disease
genes tend to have lower dN values with their mouse- (A) and
Macaca- (B) one-to-one orthologs. Furthermore, compared with
disease singletons, duplicated disease genes tend to have lower dN
values with their mouse- (C) and Macaca- (D) orthologs. The
higher selective constraints on duplicated disease genes can be also
seen within the human genome; for example, compared with
duplicated non-disease genes (ND) of similar duplication age,
disease genes tend to have lower dN values with their closest
paralogs within human (E). However the same isn’t true when age
is omitted (F), highlighting the importance of dividing gene pairs
according to their duplication age.
(EPS)
Figure S7 Dating duplication events by comparing the topologies
of gene trees with a reference species tree. A) duplication event on a
gene tree. B) the corresponding event mapped to a species tree.
(EPS)
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Figure S8 The species tree used in this study. Highlighted in red
is the time period during which the two rounds of whole genome
duplications (WGDs) likely happened.
(EPS)
Dataset S1 This supplementary file is an archive contains all the
raw data and R scripts used in this study; also included in this
archive is a detailed instruction for the readers to reproduce our
main results, including all the figures, supplementary figures, and
statistical tests except Figure 5, which was plotted manually.
(ZIP)
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